A randomized multicenter clinical study on JUC spray dressing in the treatment of atopic dermatitis (AD)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006352

Enrollment

Unknown

Registered

2015-04-20

Start date

2015-04-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Experimental group: JUC spray dressing

Control group:Topical corticosteroids

Eligibility

Sex/Gender

All

Age

1 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Children of 1 to 16 years old; 2. Patients diagnosed with AD; 3. Patients with positive bacterial culture; 4. Patients with similar lesions.

Exclusion criteria

Exclusion criteria: 1. Patients who had received local antimicrobial drugs within 2 weeks before selection; 2. Patients who had received systemic antimicrobial treatment within 4 weeks before selection; 3. Patients who are severely immunocompromised or requiring long-term application of glucocorticoid and immunosuppressants; 4. Patients with mental system disease; 5. Patients who are allergic to the used drug (allergic to ammonium salt).

Design outcomes

Primary

Measure	Time frame
bacterial culture;SCORD;	—

Countries

China

Contacts

Public ContactMin Zhongsheng/Yang Bin/Zhang Xibao

minzhsh@sina.com+86 13952091800/+86 020-87631390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026